Do you have the same question? Follow this Question
Nov 24, 2025 - 12:44 PM
We’ve provided several answers to questions related to Nubeqa (Darolutamide) , see some other helpful Q&A related to this product.
Question: Does darolutamide raise blood pressure?
Answer: Darolutamide may cause an increase in blood pressure in some patients. High blood pressure (hypertension) is listed as a possible side effect of this medication. Patients taking darolutamide should have their blood pressure monitored regularly.
Question: What is the PubChem CID for this medication?
Answer: The PubChem CID is 71302562. PubChem CIDs are used to access comprehensive chemical information, helpful for those needing detailed scientific data.
Question: Is this medication approved by any regulatory agencies?
Answer: Yes, it is approved by both the US FDA (Food and Drug Administration) and EMA (European Medicines Agency). Regulatory approval means the drug has been thoroughly evaluated for safety and efficacy, providing reassurance to patients and providers.
Question: What is the bioavailability of this medication?
Answer: The bioavailability is 30%, and it increases when taken with food. Bioavailability refers to the amount of the drug that enters the circulation, so taking it with food can make the medication more effective.
Question: What is the formula for darolutamide?
Answer: The chemical formula is C19H19ClN6O2. This provides insight into the molecular structure, which can be helpful for healthcare professionals and those interested in the science behind the drug.
